Cardiac valvulopathy associated with exposure fenfluramine or dexfenfluramine: US Department of Health and Human Services Interim Public Health Recommendations, November 1997

JAMA

Volumn 278, Issue 21, 1997, Pages 1729-1731

  Bowen, R ^a   Glicklich, A ^a   Khan, M ^a   Rasmussen, S ^a   Wadden, T ^a   Bustad, J ^a   Graham, D ^a   Green, L ^a   Lumpkin, M ^a   O'Neill, R ^a   Sobel, S ^a   Hubbard, V S ^a   Yanovski, S ^a   Sopko, G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXFENFLURAMINE; FENFLURAMINE; METHAMPHETAMINE; PHENTERMINE; PHENTERMINE RESIN; REDUCING AGENT; ANOREXIGENIC AGENT;

ADULT; AGED; APPETITE DISORDER; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG SAFETY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NOTE; PREVALENCE; PRIORITY JOURNAL; VALVULAR HEART DISEASE; WEIGHT REDUCTION; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG SURVEILLANCE PROGRAM; ECHOCARDIOGRAPHY; FOOD AND DRUG ADMINISTRATION; HEART VALVE PROSTHESIS; UNITED STATES;

ADVERSE DRUG REACTION REPORTING SYSTEMS; APPETITE DEPRESSANTS; ECHOCARDIOGRAPHY; FENFLURAMINE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HUMANS; PHENTERMINE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0031551969     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.1997.03550210025016     Document Type: Note

References (0)